phosphatidylcholines has been researched along with 10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid) | Trials (10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid) | Recent Studies (post-2010) (10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 31 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antón, R; Camacho, M; Puig, L; Vila, L | 1 |
1 other study(ies) available for phosphatidylcholines and 10-hydroxy-11,12-epoxyeicosa-5,8,14-trienoic acid
Article | Year |
---|---|
Hepoxilin B3 and its enzymatically formed derivative trioxilin B3 are incorporated into phospholipids in psoriatic lesions.
Topics: 8,11,14-Eicosatrienoic Acid; Cytosol; Epidermal Cells; Epidermis; Epoxide Hydrolases; Esterification; Humans; Hydroxyeicosatetraenoic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Psoriasis; Reference Values; Skin | 2002 |